Effects of DcsMcAb on the Expression of CD40/CD40L During the Rejection of Renal Allograft in Rat

周广臣,许纯孝,张怀强,关广骤,蒋小刚
DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2002.02.011
2002-01-01
Abstract:Objective In order to explore the anti rejection mechanism of DCsMcAb and its inhibition on CD40/CD40L expression, the expression of CD40/CD40L in rat renal isografts and allografts was studied.Methods The rats were divided into 5 experimental groups. The expression of CD40/CD40L in the renal grafts was detected by immunochemistry. Quantitative measurement was performed in each sample by computer imaging analysis.Results The survival time of rats treated with DcsMcAb or DcsMcAb+MP was longer than that of untreated group ( P 0.01 ), especially in DcsMcAb combined with MP group. The expression level of CD40/CD40L in untreated allografts was higher than other groups ( P 0.005 ). The significant decrease of CD40/CD40L expression was detected in renal grafts of DCsMcAb+MP group compared with the MP and the DCsMcAb group ( P 0.05 ). The expression level of CD40/CD40L in isografts was lowerest among all of groups.Conclusion DCs McAb or DCs McAb combined with MP can prevent the rejection of renal allografts to prolong the surival time of renal allografts; Interfering costimulatory signals conduction of CD40/CD40L costimulatory pathway might be an important mechanism of DcsMcAb anti rejection.
What problem does this paper attempt to address?